Recurrent pregnancy loss is defined as the miscarriage of three or more pregnancies prior to 20 weeks of gestation. The risk of a single miscarriage ranges from 15% to 50% or more per pregnancy, depending on the woman’s age. In contrast, approximately 1% of couples suffer from RPL. RPL is an emotionally challenging experience.
The reproductive endocrinologists at UCSF are trained specialists in the area of recurrent pregnancy loss and will offer you an evidence-based approach toward understanding miscarriage as well as towards preventing future miscarriages. In addition, we offer on-going close monitoring of all subsequent pregnancies to provide support during a generally anxiety-provoking time. We recognize the emotional toll that miscarriage can take on a couple and our team psychologist is available to provide additional emotional support to all couples with RPL. After a thorough fertility evaluation, 50% of couples with RPL will have a cause identified. Potential diagnostic testing includes the following:
In approximately 4% of couples who experience RPL, one or both partners will have an abnormality of chromosome structure. In such cases, one possible therapy is in vitro fertilization (IVF) with biopsy and chromosomal evaluation of each embryo, called pre-implantation genetic diagnosis (PGD).
Abnormalities of the uterine cavity account for approximately 15% of cases of RPL. Abnormalities may include a uterine septum (an abnormally-shaped cavity), intra-uterine scar tissue, polyps or fibroids. Diagnostic tests such as hysterosalpingograms (HSG), saline sonohysterograms, and hysteroscopy can be used to evaluate the uterine cavity. Many abnormalities within the uterine cavity can be corrected with minor surgical interventions.
In approximately 15% of couples with RPL, the cause may be related to circulating antibodies that interfere with the proper functioning of the tissue that supports the pregnancy (the placenta). Blood tests are performed to identify a set of these antibodies and, if found, the diagnosis of anti-phospholipid antibody syndrome (APS) can be made. APS has been shown to respond to treatment with blood thinning medications.
Some women with RPL have been shown to have inherited disorders that cause clots in the blood vessels to occur more easily than in other women. The link between thrombophilas and miscarriage is strongest for women experiencing losses in the late first trimester or second trimester. Evidence regarding the benefits of blood thinning medications to prevent miscarriage is currently lacking, though studies in this area are on-going.
Women with uncontrolled diabetes mellitus and uncorrected thyroid-gland dysfunction are at an elevated risk of miscarriage. Correction of hormonal imbalances is recommended in these cases.
As many as 70% of all miscarriages are due to abnormalities of the chromosomal number in the fetus. Although this problem arises in increasing frequency as women age, it is a phenomenon that occurs across all age groups. This type of miscarriage is often referred to as “random miscarriage.”
The search for a solution for RPL has led to the use of several tests and therapies not proven to be useful. These include:
As many as 50% of women with RPL will have no specific cause identified. Many couples find it quite frustrating to have no clearly identified causes for their losses. Many studies, however, have shown that with continued attempts at conception and no additional interventions, the prognosis for a future live birth remains quite good for couples with unexplained recurrent pregnancy loss. Depending on age, chances for a live-birth in subsequent pregnancies for these couples range from 50%-80%.
|The UCSF Center for Reproductive Health, located in Northern California's San Francisco Bay Area offers a comprehensive array of infertility evaluation and treatment options for both men and women. Our services include: Infertility Evaluation, Male Reproductive Health, Fertility Preservation, Reproductive Surgery, Tubal Reversal Surgery, In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Pre-implantation Genetic Diagnosis (PGD), Intrauterine Insemination (IUI), Ovulation Induction, Donor Sperm Insemination, Egg Donor Program for Donors, Egg Donor Program for Recipients, Embryo Donation Program for Donors, Embryo Donation Program for Recipients, Polycystic Ovarian Syndrome (PCOS), Recurrent Pregnancy Loss, Gestational Surrogacy, Genetic Screening and Counseling Psychological Support.|